Additionally, higher myeloma‐reactive T‐cell ratios of CD27–:CD27+ were prognostic for PFS, which may be reflective of reactivation after treatment with lenalidomide and subsequent transplant.32 Here, CD27 is linked to plasma cell myeloma.